Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000898409 | SCV001042616 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000898409 | SCV002563785 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | ZBTB20: PP2, BP4, BS1, BS2 |
Ambry Genetics | RCV002540167 | SCV003678810 | likely benign | Inborn genetic diseases | 2022-01-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV000898409 | SCV001799777 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000898409 | SCV001976101 | likely benign | not provided | no assertion criteria provided | clinical testing |